SlideShare a Scribd company logo
1 of 23
AmebiasisAmebiasis
Paul R. Earl
Facultad de Ciencias Biológicas
Universidad Autónoma de Nuevo León
San Nicolas, NL, Mexico
pearl@dsi.uanl.mx
Amebiasis or amebic dysentary is
caused by the protozoan Entamoeba
histolytica. Improved sanitation and
clean water supply decrease the
incidence of amebiasis. The amount of
chlorine normally used to control
pathogens is inadequate in killing the
cysts. Drinking water can be rendered
safe by boiling or iodination with
tetraglycine hydroperiodide.
Nevertheless, drinking water is usually
not much of the problem.
Generalities.
Amebiasis is an intestinal infection
in which cysts are passed in the feces.
Symptoms can include fever, chills and
diarrhea, sometimes bloody or with mucus
and often with cramps. Some people may
have only mild abdominal discomfort or no
symptoms at all. Symptoms can start 2 or
more weeks after infection. Rarely,
trophozoites (the mobile amebas) may
invade the liver, lung or brain, or perforate
the colon causing septicemia.
E. dispar is a nonpathogenic protozoon
morphologically identical to E histolytica.
Previously reported asymptomatic infections
due to the so-called nonpathogenic strains of
E histolytica now are recognized to be due to
E. dispar. These 2 species of Entameba can
be distinguished by monoclonal antibodies.
Other morphologically distinct organisms,
such as Entamoeba coli ( E. coli ! ! ) and
Entamoeba hartmanni are also
nonpathogenic.
Amebiasis is the third leading
parasitic cause of death worldwide,
surpassed only by malaria and
schistosomiasis. On a global basis,
amebiasis affects approximately 50
million persons each year,
resulting in nearly 100,000 deaths.
Laboratory diagnosis.
An iodine-stained cyst of the pathogen
Entamoeba hystolytica with 4 nuclei is illustrated.
The harmless commensal Entamoeba coli has
larger cyts with 8 nuclei. Furthermore, recall that
E. histolytica has a lookalike E. dispars that is
harmless.
The cyst of E histolytica averages 12
µm, ranging from 5-20 µm. It has 1-4
nuclei that are morphologically similar
to the nuclei of the trophozoite. The
cyst may have iodine-stainable
glycogen clumps and chromatoid
bodies with smooth rounded edges.
The ending –oid means LIKE so
chromatoid bodies are like chromatin
in that they stain with hematoxylin.
Trophozoites
Entamoeba coli Entamoeba histolytica
15 µm - 40 µm in size 10 µm - 35 µm size
Nondirectional motility Unidirectional motility
Multiple pseudopodia Single pseudopodia
No ingested erythrocytes Ingested erythrocytes
Cytoplasm rough looking Finely granular cytoplasm
Large, eccentric karyosome Small, central karyosome
Clumped nuclear chromatin Finely beaded chromatin
Cysts
Entamoeba coli Entamoeba histolytica
10 µm - 35 µm in size 10 µm - 20 µm in size
May have 8 nuclei Never more than 4 nuclei
Karyosomes eccentric Karyosomes small, central
Nuclear chromatin clumped Chromatin finely beaded
Splintered chromatoidal bars Rounded chromatoidal bars
Leukocytosis and mild anemia can occur.
Erythrocyte sedimentation rate generally
is elevated. Liver function tests reveal
elevated alkaline phosphatase in 80% of
patients, elevated transaminases and
reduced albumin. Urinalysis may reveal
proteinuria.
Rectosigmoidoscopy and colonoscopy
may show small mucosal ulcers covered
with yellowish exudates. The intervening
mucosa appears normal. Biopsy results
and scrapings of ulcer edge may locate
trophozoites.
Symptoms and pathology.
Primary intestinal flask-shaped
(button hole) necrotic ulcers occur in
the submucosa of the large intestine,
most commonly the cecal and
sigmoidorectal regions.Ulcers contain
necrotic debris, actively feeding
trophozoites with ingested
erythrocytes, cytolyzed cells and
mucous; polymorphonuclear
leukocytes and round inflammatory
cells.
Extraintestinal features.
Hematogenous spread may result in
abscesses of the liver, spleen, lung or
brain. Hepatic amebiasis (abscess,
hepatitis) is the most common and
grave complication: Enlarged, tender
liver and upper abdominal pain that
may radiate to the right shoulder.
Mild jaundice may be evident,
transaminases and alkaline
phosphatase elevations may be seen.
Drugs for treatment.
Five pharmaceuticals are briefly noted.
Asymptomatic intestinal infection may be
treated with iodoquinol, paromomycin or
diloxanide furoate. Recommended drugs
for treatment of symptomatic intestinal
disease and for hepatic abscess are
metronidazole and tinidazole. Since these
drugs may not eliminate the cysts of the
intestine, immediately follow
metronidazole and tinidazole with
iodoquinol, paromomycin or diloxanide
furoate.
1/ Metronidazole (Flagyl,
Protostat). Kills trophozoites of E.
histolytica in intestine and tissue.
Does not eradicate cysts from
intestines. Adult oral dose: 500-
750 mg 3 times per day for 10
day. Elimination is accelerated by
simultaneous use of phenytoin
and phenobarbital; clearance is
decreased by cimetidine.
2/Tinidazole (Fasigyn). 5-
nitroimidazole derivative with
selective antimicrobial activity
against anaerobic bacteria and
protozoa. Not available in United
States. Adult oral dose: 600 mg
bid or 800 mg 2 times a day for 5
days. Pediatric dose 50-60 mg/kg
for 5 days, not to exceed 2 g/day.
3/Paromomycin (Humatin).
Amebicidal aminoglycoside antibiotic
that is poorly absorbed. Active only
against intestinal form of amebiasis.
Used to eradicate cysts of E.
histolytica following treatment with
metronidazole or tinidazole for an
invasive disease. Adult oral dose:
25-35 mg/kg/day divided 3 times
for 7 days. Pediatric dose:
Administer as in adults.
4/Diloxanide furoate (Furamid,
Entamizole, Furamide). Luminal
amebicide; acts primarily in bowel
lumen since it is poorly absorbed.
Used to eradicate cysts of E. histolytica
after treatment of invasive disease.
Available through US CDC Drug
Service (404-639-3670). Adult oral
dose 500 mg 2 times a day for 10
days. Pediatric dose 20 mg/kg/
divided twice a day for 10 days, not to
exceed 1500 mg/day.
5/Iodoquinol (Yodoxin). Halogenated
hydroxyquinoline. Luminal amebicide;
acts primarily in bowel lumen since it is
poorly absorbed. Best tolerated when
given with meals. Since active only
against intraluminal form of amebiasis,
used to eradicate cysts of E. histolytica
after treatment of invasive disease. Adult
oral dose 650 mg 2 times a day for 20
days. Pediatric dose: 30-40 mg/kg/day
divided 2 times for 20 days; not to
exceed 2 g/day.
The control of infection.
The epidemiology of amebiasis is
folkloric, beginning with infected
foodhandlers. While elements of
truth are scattered through this
neglected syndrome, much more
can be done. Frankly, the ecology
is unknown. Are there reservoir
animals?
What civic water treatments kill and
which ones tolerate E. histolytica? What
part does chronic malnutrition play in
susceptibility to infection? What part
does exposure then the rise of natural
antibodies play in defense? What are the
water-borne pathogens intimately
associated with E. histolytica? Has
radioactivity been used to trace
ecological dispersion of an element like
phosphorus in a parasite? If ever, how is
E. histolytica considered in civic water
management?
The main point of this lecture
is to sketch E. histolytica as a
distinct pathogen differing from
E. coli and E. dispar. More,
decades pass without fruitful
reseach results. Perhaps you
find this a challenge.

More Related Content

What's hot

Abdul ppt smnr ; u can contact me mannanhkd4@gmail.com
Abdul ppt smnr ; u  can contact me mannanhkd4@gmail.comAbdul ppt smnr ; u  can contact me mannanhkd4@gmail.com
Abdul ppt smnr ; u can contact me mannanhkd4@gmail.com
microhicc
 
Causesof diarrheal diseases
Causesof diarrheal diseasesCausesof diarrheal diseases
Causesof diarrheal diseases
Nikhil Gupta
 

What's hot (20)

Dysentery
DysenteryDysentery
Dysentery
 
Relapsing fever notes
Relapsing fever notesRelapsing fever notes
Relapsing fever notes
 
Typhoid (Enteric fever)
Typhoid (Enteric fever)Typhoid (Enteric fever)
Typhoid (Enteric fever)
 
Filariasis
FilariasisFilariasis
Filariasis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Dracunculiasis
DracunculiasisDracunculiasis
Dracunculiasis
 
Abdul ppt smnr ; u can contact me mannanhkd4@gmail.com
Abdul ppt smnr ; u  can contact me mannanhkd4@gmail.comAbdul ppt smnr ; u  can contact me mannanhkd4@gmail.com
Abdul ppt smnr ; u can contact me mannanhkd4@gmail.com
 
HIV infection clinical Classification & Systemic manifestations
HIV infection clinical Classification & Systemic manifestationsHIV infection clinical Classification & Systemic manifestations
HIV infection clinical Classification & Systemic manifestations
 
Dengue virus
Dengue virus  Dengue virus
Dengue virus
 
Dysentery
DysenteryDysentery
Dysentery
 
Amebiasis
AmebiasisAmebiasis
Amebiasis
 
Pertussis (whooping cough) dr harivansh chopra
Pertussis (whooping cough) dr harivansh chopraPertussis (whooping cough) dr harivansh chopra
Pertussis (whooping cough) dr harivansh chopra
 
TB awareness
TB awarenessTB awareness
TB awareness
 
Causesof diarrheal diseases
Causesof diarrheal diseasesCausesof diarrheal diseases
Causesof diarrheal diseases
 
Malaria ppt.
Malaria ppt.Malaria ppt.
Malaria ppt.
 
Desentery
DesenteryDesentery
Desentery
 
Yellow Fever - The Disease
Yellow  Fever - The DiseaseYellow  Fever - The Disease
Yellow Fever - The Disease
 
Poliomyelitis
PoliomyelitisPoliomyelitis
Poliomyelitis
 
Japanese encephalitis
Japanese encephalitis Japanese encephalitis
Japanese encephalitis
 
Dysentery
DysenteryDysentery
Dysentery
 

Viewers also liked (20)

Amebiasis
AmebiasisAmebiasis
Amebiasis
 
11491
1149111491
11491
 
Amebiasis
AmebiasisAmebiasis
Amebiasis
 
Amoebiasis
AmoebiasisAmoebiasis
Amoebiasis
 
Entamoeba histolytica
Entamoeba histolyticaEntamoeba histolytica
Entamoeba histolytica
 
Amoeba powerpoint ally
Amoeba powerpoint  allyAmoeba powerpoint  ally
Amoeba powerpoint ally
 
Amebiasis
AmebiasisAmebiasis
Amebiasis
 
Amebiasis
AmebiasisAmebiasis
Amebiasis
 
Amebiasis
AmebiasisAmebiasis
Amebiasis
 
Amoeba
AmoebaAmoeba
Amoeba
 
Anti Amoebic Drugs
Anti Amoebic DrugsAnti Amoebic Drugs
Anti Amoebic Drugs
 
Amoeba
AmoebaAmoeba
Amoeba
 
Amebiasis Maria Iyali Poceros Coba
Amebiasis Maria Iyali Poceros CobaAmebiasis Maria Iyali Poceros Coba
Amebiasis Maria Iyali Poceros Coba
 
6.1 amebiasis
6.1 amebiasis6.1 amebiasis
6.1 amebiasis
 
Amebiasis
AmebiasisAmebiasis
Amebiasis
 
Treatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasisTreatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasis
 
Amebiase
AmebiaseAmebiase
Amebiase
 
Entamoeba
EntamoebaEntamoeba
Entamoeba
 
Amibiasis
AmibiasisAmibiasis
Amibiasis
 
Amoeba
AmoebaAmoeba
Amoeba
 

Similar to 10921

A Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptxA Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptx
KunalGowda2
 
microbiology imp. Flagellates ppt
microbiology imp. Flagellates pptmicrobiology imp. Flagellates ppt
microbiology imp. Flagellates ppt
joydeep1886
 
Intestinal and Urogenital Protozoa
Intestinal and Urogenital ProtozoaIntestinal and Urogenital Protozoa
Intestinal and Urogenital Protozoa
Jessabeth Aluba
 
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
Ofooni1_08_Amebiasis_GiardiaInfection.pptxOfooni1_08_Amebiasis_GiardiaInfection.pptx
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
AliAmrollahzade
 
Intestinal protosoa
Intestinal protosoaIntestinal protosoa
Intestinal protosoa
Jasmine John
 

Similar to 10921 (20)

Amebiasis.ppt
Amebiasis.pptAmebiasis.ppt
Amebiasis.ppt
 
Parasitic infestation june 2020
Parasitic infestation june 2020Parasitic infestation june 2020
Parasitic infestation june 2020
 
Intestinal amoebae
Intestinal amoebaeIntestinal amoebae
Intestinal amoebae
 
Intestinal amoebae
Intestinal amoebaeIntestinal amoebae
Intestinal amoebae
 
A Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptxA Brief PPT about Amoebiasis.pptx
A Brief PPT about Amoebiasis.pptx
 
Amoebiasis 22
Amoebiasis 22Amoebiasis 22
Amoebiasis 22
 
microbiology imp. Flagellates ppt
microbiology imp. Flagellates pptmicrobiology imp. Flagellates ppt
microbiology imp. Flagellates ppt
 
Intestinal and Urogenital Protozoa
Intestinal and Urogenital ProtozoaIntestinal and Urogenital Protozoa
Intestinal and Urogenital Protozoa
 
AMOEBIASIS & GIARDIASIS
AMOEBIASIS & GIARDIASIS AMOEBIASIS & GIARDIASIS
AMOEBIASIS & GIARDIASIS
 
Giardia+Entamoeba
Giardia+EntamoebaGiardia+Entamoeba
Giardia+Entamoeba
 
3-_Giardia_lamblia[1].ppt
3-_Giardia_lamblia[1].ppt3-_Giardia_lamblia[1].ppt
3-_Giardia_lamblia[1].ppt
 
Entamoeba histolytica
Entamoeba histolytica Entamoeba histolytica
Entamoeba histolytica
 
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
Ofooni1_08_Amebiasis_GiardiaInfection.pptxOfooni1_08_Amebiasis_GiardiaInfection.pptx
Ofooni1_08_Amebiasis_GiardiaInfection.pptx
 
Amoebiasis.pptx
Amoebiasis.pptxAmoebiasis.pptx
Amoebiasis.pptx
 
Entamoeba by-manoj
Entamoeba by-manojEntamoeba by-manoj
Entamoeba by-manoj
 
Intestinal protosoa
Intestinal protosoaIntestinal protosoa
Intestinal protosoa
 
Entamoeba Coli.pptx
Entamoeba Coli.pptxEntamoeba Coli.pptx
Entamoeba Coli.pptx
 
Giardia lamblia
Giardia lambliaGiardia lamblia
Giardia lamblia
 
Protozoa and Entamoeba histolytica
Protozoa and Entamoeba histolyticaProtozoa and Entamoeba histolytica
Protozoa and Entamoeba histolytica
 
Microbial Diseases in our Digestive System
Microbial Diseases in our Digestive SystemMicrobial Diseases in our Digestive System
Microbial Diseases in our Digestive System
 

More from khartoum

Amoebiasis 090528093701-phpapp01
Amoebiasis 090528093701-phpapp01Amoebiasis 090528093701-phpapp01
Amoebiasis 090528093701-phpapp01
khartoum
 
Entamoebahistolytica 2-100609161916-phpapp01
Entamoebahistolytica 2-100609161916-phpapp01Entamoebahistolytica 2-100609161916-phpapp01
Entamoebahistolytica 2-100609161916-phpapp01
khartoum
 
Amebiasis karshenasi
Amebiasis  karshenasiAmebiasis  karshenasi
Amebiasis karshenasi
khartoum
 
Diagnosisand treatmentofvaginitistaylor09 15-10withdisclosure
Diagnosisand treatmentofvaginitistaylor09 15-10withdisclosureDiagnosisand treatmentofvaginitistaylor09 15-10withdisclosure
Diagnosisand treatmentofvaginitistaylor09 15-10withdisclosure
khartoum
 
Amebiasis karshenasi (1)
Amebiasis  karshenasi (1)Amebiasis  karshenasi (1)
Amebiasis karshenasi (1)
khartoum
 

More from khartoum (7)

Amoebiasis 090528093701-phpapp01
Amoebiasis 090528093701-phpapp01Amoebiasis 090528093701-phpapp01
Amoebiasis 090528093701-phpapp01
 
Entamoebahistolytica 2-100609161916-phpapp01
Entamoebahistolytica 2-100609161916-phpapp01Entamoebahistolytica 2-100609161916-phpapp01
Entamoebahistolytica 2-100609161916-phpapp01
 
Amebiasis karshenasi
Amebiasis  karshenasiAmebiasis  karshenasi
Amebiasis karshenasi
 
Diagnosisand treatmentofvaginitistaylor09 15-10withdisclosure
Diagnosisand treatmentofvaginitistaylor09 15-10withdisclosureDiagnosisand treatmentofvaginitistaylor09 15-10withdisclosure
Diagnosisand treatmentofvaginitistaylor09 15-10withdisclosure
 
Amebiasis karshenasi (1)
Amebiasis  karshenasi (1)Amebiasis  karshenasi (1)
Amebiasis karshenasi (1)
 
Amoebiasis
AmoebiasisAmoebiasis
Amoebiasis
 
Amoebiasis
AmoebiasisAmoebiasis
Amoebiasis
 

10921

  • 1. AmebiasisAmebiasis Paul R. Earl Facultad de Ciencias Biológicas Universidad Autónoma de Nuevo León San Nicolas, NL, Mexico pearl@dsi.uanl.mx
  • 2. Amebiasis or amebic dysentary is caused by the protozoan Entamoeba histolytica. Improved sanitation and clean water supply decrease the incidence of amebiasis. The amount of chlorine normally used to control pathogens is inadequate in killing the cysts. Drinking water can be rendered safe by boiling or iodination with tetraglycine hydroperiodide. Nevertheless, drinking water is usually not much of the problem.
  • 3. Generalities. Amebiasis is an intestinal infection in which cysts are passed in the feces. Symptoms can include fever, chills and diarrhea, sometimes bloody or with mucus and often with cramps. Some people may have only mild abdominal discomfort or no symptoms at all. Symptoms can start 2 or more weeks after infection. Rarely, trophozoites (the mobile amebas) may invade the liver, lung or brain, or perforate the colon causing septicemia.
  • 4. E. dispar is a nonpathogenic protozoon morphologically identical to E histolytica. Previously reported asymptomatic infections due to the so-called nonpathogenic strains of E histolytica now are recognized to be due to E. dispar. These 2 species of Entameba can be distinguished by monoclonal antibodies. Other morphologically distinct organisms, such as Entamoeba coli ( E. coli ! ! ) and Entamoeba hartmanni are also nonpathogenic.
  • 5. Amebiasis is the third leading parasitic cause of death worldwide, surpassed only by malaria and schistosomiasis. On a global basis, amebiasis affects approximately 50 million persons each year, resulting in nearly 100,000 deaths.
  • 6. Laboratory diagnosis. An iodine-stained cyst of the pathogen Entamoeba hystolytica with 4 nuclei is illustrated. The harmless commensal Entamoeba coli has larger cyts with 8 nuclei. Furthermore, recall that E. histolytica has a lookalike E. dispars that is harmless.
  • 7.
  • 8.
  • 9. The cyst of E histolytica averages 12 µm, ranging from 5-20 µm. It has 1-4 nuclei that are morphologically similar to the nuclei of the trophozoite. The cyst may have iodine-stainable glycogen clumps and chromatoid bodies with smooth rounded edges. The ending –oid means LIKE so chromatoid bodies are like chromatin in that they stain with hematoxylin.
  • 10. Trophozoites Entamoeba coli Entamoeba histolytica 15 µm - 40 µm in size 10 µm - 35 µm size Nondirectional motility Unidirectional motility Multiple pseudopodia Single pseudopodia No ingested erythrocytes Ingested erythrocytes Cytoplasm rough looking Finely granular cytoplasm Large, eccentric karyosome Small, central karyosome Clumped nuclear chromatin Finely beaded chromatin
  • 11. Cysts Entamoeba coli Entamoeba histolytica 10 µm - 35 µm in size 10 µm - 20 µm in size May have 8 nuclei Never more than 4 nuclei Karyosomes eccentric Karyosomes small, central Nuclear chromatin clumped Chromatin finely beaded Splintered chromatoidal bars Rounded chromatoidal bars
  • 12. Leukocytosis and mild anemia can occur. Erythrocyte sedimentation rate generally is elevated. Liver function tests reveal elevated alkaline phosphatase in 80% of patients, elevated transaminases and reduced albumin. Urinalysis may reveal proteinuria. Rectosigmoidoscopy and colonoscopy may show small mucosal ulcers covered with yellowish exudates. The intervening mucosa appears normal. Biopsy results and scrapings of ulcer edge may locate trophozoites.
  • 13. Symptoms and pathology. Primary intestinal flask-shaped (button hole) necrotic ulcers occur in the submucosa of the large intestine, most commonly the cecal and sigmoidorectal regions.Ulcers contain necrotic debris, actively feeding trophozoites with ingested erythrocytes, cytolyzed cells and mucous; polymorphonuclear leukocytes and round inflammatory cells.
  • 14. Extraintestinal features. Hematogenous spread may result in abscesses of the liver, spleen, lung or brain. Hepatic amebiasis (abscess, hepatitis) is the most common and grave complication: Enlarged, tender liver and upper abdominal pain that may radiate to the right shoulder. Mild jaundice may be evident, transaminases and alkaline phosphatase elevations may be seen.
  • 15. Drugs for treatment. Five pharmaceuticals are briefly noted. Asymptomatic intestinal infection may be treated with iodoquinol, paromomycin or diloxanide furoate. Recommended drugs for treatment of symptomatic intestinal disease and for hepatic abscess are metronidazole and tinidazole. Since these drugs may not eliminate the cysts of the intestine, immediately follow metronidazole and tinidazole with iodoquinol, paromomycin or diloxanide furoate.
  • 16. 1/ Metronidazole (Flagyl, Protostat). Kills trophozoites of E. histolytica in intestine and tissue. Does not eradicate cysts from intestines. Adult oral dose: 500- 750 mg 3 times per day for 10 day. Elimination is accelerated by simultaneous use of phenytoin and phenobarbital; clearance is decreased by cimetidine.
  • 17. 2/Tinidazole (Fasigyn). 5- nitroimidazole derivative with selective antimicrobial activity against anaerobic bacteria and protozoa. Not available in United States. Adult oral dose: 600 mg bid or 800 mg 2 times a day for 5 days. Pediatric dose 50-60 mg/kg for 5 days, not to exceed 2 g/day.
  • 18. 3/Paromomycin (Humatin). Amebicidal aminoglycoside antibiotic that is poorly absorbed. Active only against intestinal form of amebiasis. Used to eradicate cysts of E. histolytica following treatment with metronidazole or tinidazole for an invasive disease. Adult oral dose: 25-35 mg/kg/day divided 3 times for 7 days. Pediatric dose: Administer as in adults.
  • 19. 4/Diloxanide furoate (Furamid, Entamizole, Furamide). Luminal amebicide; acts primarily in bowel lumen since it is poorly absorbed. Used to eradicate cysts of E. histolytica after treatment of invasive disease. Available through US CDC Drug Service (404-639-3670). Adult oral dose 500 mg 2 times a day for 10 days. Pediatric dose 20 mg/kg/ divided twice a day for 10 days, not to exceed 1500 mg/day.
  • 20. 5/Iodoquinol (Yodoxin). Halogenated hydroxyquinoline. Luminal amebicide; acts primarily in bowel lumen since it is poorly absorbed. Best tolerated when given with meals. Since active only against intraluminal form of amebiasis, used to eradicate cysts of E. histolytica after treatment of invasive disease. Adult oral dose 650 mg 2 times a day for 20 days. Pediatric dose: 30-40 mg/kg/day divided 2 times for 20 days; not to exceed 2 g/day.
  • 21. The control of infection. The epidemiology of amebiasis is folkloric, beginning with infected foodhandlers. While elements of truth are scattered through this neglected syndrome, much more can be done. Frankly, the ecology is unknown. Are there reservoir animals?
  • 22. What civic water treatments kill and which ones tolerate E. histolytica? What part does chronic malnutrition play in susceptibility to infection? What part does exposure then the rise of natural antibodies play in defense? What are the water-borne pathogens intimately associated with E. histolytica? Has radioactivity been used to trace ecological dispersion of an element like phosphorus in a parasite? If ever, how is E. histolytica considered in civic water management?
  • 23. The main point of this lecture is to sketch E. histolytica as a distinct pathogen differing from E. coli and E. dispar. More, decades pass without fruitful reseach results. Perhaps you find this a challenge.

Editor's Notes

  1. Perhaps vegetables grown in untreated drainage (aguas negras) should be iodinized or treated with caution. Amebiasis, famous by transmission by foodhandlers, can be also transmitted on the surface of foods. The larger problem is water supply & drainage, particularly in agricultural countries as in much of Latin America. Recycling scarce water is one very large civic task, and safely fertilizing crops with drainage is another. At the same time, the demand for sanitary services is increasing, because of the population explosion. Then the question can be: What is the role of E. histolytica in current and future water management problems?
  2. Cerebral amebiasis is fatal. Cysts are spread from one person to another directly or via contaminated objects or in food or water. People are infectious as long as the cysts are being shed in their feces. When others touch the objects or eat contaminated food, they get the cysts on their hands and into their mouths. When they swallow the cysts, they get infected. Diagnosis is made by examining fecal samples under the microscope for the presence of trophozoites and cysts of Entamoeba histolytica..
  3. In 1875 in St. Petersburg, Russia, Losch first described amebiasis, proving the ameba’s pathogenicity by infecting a dog with fecal cysts from a hospital patient. Councilman & Lafleur at Johns Hopkins University Hospital, Baltimore, Md, USA distinguished between bacillary and amebic dysentery in 1891.
  4. Many other amebas and flagellates inhabit the human intestine, mostly harmless. Regardless, they should be recognized by anyone diagnosing fecal samples. Illustrations are through the courtesy of Chiang Mai University, Thailand: dept/parasite/image.htm.
  5. Indications for endoscopy in suspected intestinal amebiasis include the following: a) serum antibody positive, yet feces negative, b) immediate diagnosis required and feces negative, c) high suspicion without evidence, and d) evaluation of lesions.
  6. Patients can have chronic protracted diarrhea, dysentery (minority), cramping abdominal pain and tenderness. Fever may result from bacterial superinfections. red blood cells, neutrophils, mucus and shreds of necrotic mucosa may be seen in stool specimens.Complications include appendicitis, perforation, hemorrhage, stricture and pseudopolyposis. Chronic irritable colon or postdysenteric colitis may be experienced.
  7. Most infections lead to uneventful recoveries. However. fulminant amebic colitis has a mortality rate of more than 50%, whereas pleuropulmonary amebiasis has a mortality rate of 15-20%, amebic pericarditis has a case fatality rate of 40%.
  8. Have these and other drugs including the antimitotic type been adequately tested in in vitro, i. e., in trophozoite and cyst cultures? They have not. Is simple mitosis understood? It is not.
  9. Is patient data well anaylzed by locality, income, age, sex, etc. Would questionaires help? Are these patients rural, migrant or urban? How does amebiasis relate to rural poverty? Where did certain travelers become infected? Is amebiasis a medical, a water-and-drainage or a social problem? Is underfinancing of research a problem? What distinguishes persons with antibodies against E. histolytica from others without?